PGI<sub>2</sub> as a Regulator of Inflammatory Diseases

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left">Agent</td><td align="center">Pharmacology</td><td align="center">Indications</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">Epoprostenol</td><td align="center">Synthetic salt of PGI<sub>2</sub></td><td align="center">PAH, transplantation, renal dialysis, and extracorporeal circulation systems</td></tr><tr><td align="left">Treprostinil</td><td align="center">IP receptor agonist</td><td align="center">PAH</td></tr><tr><td align="left">Iloprost</td><td align="center">IP receptor agonist</td><td align="center">PAH</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Therapeutic use of PGI<sub>2</sub>—approved agents.

Mediators of Inflammation

tab1

Table 1

Table 1: PGI<sub>2</sub> as a Regulator of Inflammatory Diseases 

Mediators of Inflammation

PGI2 as a Regulator of Inflammatory Diseases

Table 1

PGI₂ as a Regulator of Inflammatory Diseases